Bio-Techne
TECH
#2010
Rank
NZ$16.58 B
Marketcap
NZ$106.42
Share price
0.17%
Change (1 day)
-19.06%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): NZ$0.89

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$0.83. In 2024 the company made an earnings per share (EPS) of NZ$1.66 a decrease over its 2023 EPS that were of NZ$2.36.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.89-46.53%
2024NZ$1.66-29.58%
2023NZ$2.36-14.97%
2022NZ$2.7724.16%
2021NZ$2.2317.98%
2020NZ$1.89-10.94%
2019NZ$2.13101.57%
2018NZ$1.05-16.99%
2017NZ$1.2745.02%
2016NZ$0.88-20.97%
2015NZ$1.11-14.97%
2014NZ$1.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$28.79 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.25 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$12.55 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$8.10 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.10 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.35-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ-$40.36-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA